Copy number variation in bipolar disorder

Molecular Psychiatry

Volumn 21, Issue 1, 2016, Pages 89-93

  Green, E K ^a   Rees, E ^b   Walters, J T R ^b   Smith, K G ^c   Forty, L ^b   Grozeva, D ^d   Moran, J L ^e   Sklar, P ^f   Ripke, S ^e,g   Chambert, K D ^e   Genovese, G ^e   McCarroll, S A ^e   Jones, I ^b   Jones, L ^c   Owen, M J ^b   O'Donovan, M C ^b   Craddock, N ^b   Kirov, G ^b  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 7 INTERACTING PROTEIN 2; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; CHROMOSOME 16P; CHROMOSOME DUPLICATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; GENE FREQUENCY; GENE LOCUS; GENOME; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; CAUCASIAN; COMPARATIVE STUDY; FEMALE; GENETICS; GENOTYPING TECHNIQUE; MALE; MIDDLE AGED;

BIPOLAR DISORDER; DNA COPY NUMBER VARIATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 84951908465     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.174     Document Type: Article

References (37)

1. Craddock N, Owen MJ. The Kraepelinian dichotomy - going, going... but still not gone. Br J Psychiatry 2010; 196: 92-95.
2. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013; 381: 1654-1662.
3. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2010; 15: 1016-1022.
4. Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder casecontrol sample. Mol Psychiatry 2013; 18: 1302-1307.
5. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D et al. Genomewide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 2013; 18: 708-712.
6. Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 13711379.
7. Psychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
8. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
9. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
10. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012; 148: 1223-1241.
11. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012; 367: 1321-1331.
12. Kirov G, Rees E, Walters JT, Escott-Price V, Georgieva L, Richards AL et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry 2014; 75: 378-385.
13. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010; 376: 1401-1408.
14. Owen MJ, O'Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 2011; 198: 173-175.
15. Rees E, Walters JT, Georgieva L, Isles AR, Chambert KD, Richards AL et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 2014; 204: 108-114.
16. Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, Green EK et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 2010; 67: 318-327.
17. Zhang D, Cheng L, Qian Y, Alliey-Rodriguez N, Kelsoe JR, Greenwood T et al. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 2009; 14: 376-380.
18. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genomewide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012; 17: 880-886.
19. McQuillin A, Bass N, Anjorin A, Lawrence J, Kandaswamy R, Lydall G et al. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur J Hum Genet 2011; 19: 588-592.
20. Priebe L, Degenhardt FA, Herms S, Haenisch B, Mattheisen M, Nieratschker V et al. Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry 2012; 17: 421-432.
21. Malhotra D, McCarthy S, Michaelson JJ, Vacic V, Burdick KE, Yoon S et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011; 72: 951-963.
22. Georgieva L, Rees E, Moran JL, Chambert KD, Milanova V, Craddock N et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum Mol Genet 2014; 24: 6677-6683.
23. Grozeva D, Kirov G, Conrad DF, Barnes CP, Hurles M, Owen MJ et al. Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disord 2013; 15: 893-898.
24. Rees E, Walters JT, Chambert KD, O'Dushlaine C, Szatkiewicz J, Richards AL et al. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet 2014; 23: 1669-1676.
25. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593.
26. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 773-782.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA: Washington (DC) 1994.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
29. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142.
30. Girirajan S, Dennis MY, Baker C, Malig M, Coe BP, Campbell CD et al. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am J Hum Genet 2013; 92: 221-237.
31. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
32. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009; 41: 1223-1227.
33. Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S et al. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry 2014; 19: 108-114.
34. Degenhardt F, Priebe L, Herms S, Mattheisen M, Mühleisen TW, Meier S et al. Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 263-273.
35. Nurnberger JI Jr, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014; 71: 657-664.
36. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
37. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004; 71: 405-416.